XT
AEON icon

XTX Topco’s AEON Biopharma AEON Stock Holding History

XTX Topco’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.1K Sell
20,424
-36,428
-64% -$40.7K ﹤0.01% 3550
2025
Q4 		$62.5K Buy
56,852
+40,690
+252% +$38K ﹤0.01% 2780
2025
Q3 		$13.1K Buy
+16,162
New +$12.5K ﹤0.01% 2405

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco's AEON Position: Q1 2026 in Review

XTX Topco reduced its AEON Biopharma (AEON) stake by 64% in Q1 2026, selling an estimated $40.7K and leaving 20,424 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3550.

XTX Topco first reported a position in AEON in Q3 2025 and has held it in 3 quarters since. The position peaked at $62.5K in Q4 2025. 24 funds tracked by Wall St. Rank hold AEON as of Q1 2026.

  • XTX Topco held 20,424 shares of AEON Biopharma worth $20.1K as of Q1 2026.
  • XTX Topco sold 36,428 AEON Biopharma shares in Q1 2026, an estimated $40.7K.
  • AEON Biopharma made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3550 holding.
  • XTX Topco first reported a position in AEON Biopharma in Q3 2025 and has held it in 3 quarters since.
  • XTX Topco's AEON Biopharma position peaked at $62.5K in Q4 2025.
  • 24 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.